Email Newsletters

Life Sciences

Thermo Completes Purchase

Thermo Fisher Scientific, the Waltham-based biotech company with operations in Central Massachusetts, has completed its acquisition of...

ACT Enters Stem Cell Agreement

Advanced Cell Technology Inc. of Marlborough has reached an agreement with a Scottish company to establish new...

Life Sciences Center Issues New Round Of Tax Incentives

Six Central Massachusetts firms will benefit from the latest round of tax incentives issued by the Massachusetts...

Caliper Completes CRi Purchase

Hopkinton-based biotech company Caliper Life Sciences has completed its $20-million purchase of Cambridge Research & Instrumentation. The...
ADVERTISEMENT

RXi Moves Toward Drug Development

Worcester's RXi Pharmaceuticals is taking a step toward developing its first therapeutic product.The product candidate could reduce...

CEO Of Worcester Biotech Dies

William M. Caldwell IV, chairman and CEO of Worcester-based Advanced Cell Technology, died unexpectedly on Monday.The company's...

Caliper Buys Cambridge Co. For $20M

Hopkinton's Caliper Life Sciences Inc. has announced it will acquire Cambridge Research & Instrumentation Inc. for about...

Community Colleges Score Biotech Endorsements

A Massachusetts biotechnology industry group has given its stamp of approval to training programs at eight community...
ADVERTISEMENT

Littleton Firm Partners With Brown U

Littleton-based Audax Medical has licensed a nanotechnology called Arxis from Brown University in Providence that could regenerate...

Research Co. Hires Charles River Scientist

Biomedical Research Models Inc./Biomere, a contract research organization based in Worcester and Maryland, has hired Dr....
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA